Archive for February, 2017

Right Turn: New stem cell product for ALS seeking approval in Canada

Author: Stacey Johnson, 02/24/17

This week, BrainStorm Cell Therapeutics issued a news release announcing its intent to seek early regulatory approval to distribute its Amyotrophic Lateral Sclerosis (ALS) product to patients in Canada. This news was eagerly received by patient groups in Canada and internationally. ALS, also known as Lou Gehrig’s Disease, is a progressive neuromuscular disease in which…Read more

If your body isn’t healing, your partner’s genes might be to blame

Author: Jovana Drinjakovic, 02/22/17

Choosing the right partner in life can help overcome its many pitfalls and challenges. But what if that partner could also influence your health in totally unexpected ways—what if their genes, and not only yours, are at play? This, at least, seems to be the case in mice where the health of one mouse is…Read more

Right Turn: Checking in on Research2Reality

Author: Stacey Johnson, 02/17/17

Research2Reality will soon be celebrating its 2nd anniversary. I first wrote about it when it launched and was excited by its mission to highlight the work of scientists across Canada, from a variety of disciplines, and make their research interesting and understandable to a non-expert audience. Through videos and blogs, Research2Reality is “shining a light…Read more

Cells…in a box

Author: Guest, 02/13/17

Heather Blumenthal has been writing about health and health research for more than 20 years and never loses her fascination with the advances Canadian researchers are making. You can reach her at hblumenthal@sympatico.ca It’s like magic – insert a cancer patient’s blood cells in one end and out the other end come T-cells adapted for…Read more

Right Turn: Synthetic biology predicted to become a huge industry

Author: Stacey Johnson, 02/10/17

There is a trend in the regenerative medicine field to include gene therapies when describing the work being performed by academics and industry, as in “cell and gene therapies.” The wider definition better reflects how the industry is evolving and acknowledges the dual focus. I expect the same may happen with synthetic biology’s role in…Read more

Learning About Industry from the Insiders at Phacilitate Cell and Gene Therapy World 2017

Author: Nicole Forgione, 02/08/17

In January, I attended Phacilitate’s Cell and Gene Therapy World in Miami, Florida. At this meeting industry leaders from around the world gather to discuss manufacturing, regulation and adoption of cell and gene therapies (C&GT). This was my first industry-focused conference, and it was a great chance to learn the ropes from experienced players in…Read more

Right Turn: Valentine’s Day and the scientist

Author: Stacey Johnson, 02/03/17

The clock is ticking. Valentine’s Day is less than two weeks away. If you are flying solo this Valentine’s Day, I give you permission to stop reading here. (But it may be worth your while to stick around a little longer; remember the trend of single women buying diamond rings for themselves?) Valentine’s Day, despite…Read more